Novartis AG News Headlines

NVS 
$90.15
*  
0.91
1.02%
Get NVS Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVS After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Novartis: Gilenia Clears Latest Regulatory Hurdle With Ease
6/11/2010 1:01:00 PM - Seeking Alpha


The World Cup Series: Emerging Markets of the Cup - Slovenia
6/9/2010 6:48:00 AM - Seeking Alpha


Equities Update: Late Surge Helps All but Tech
6/8/2010 4:30:00 PM - Seeking Alpha


Amgen's New Double-Play Drug (AMGN, MRK, GSK, LLY, NVS)
6/8/2010 1:01:00 PM - Investopedia


Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug
6/2/2010 3:45:00 AM - Seeking Alpha


Just One Stock: This Food Giant Is a Recipe for Low-Risk Wealth Creation
6/1/2010 8:39:00 AM - Seeking Alpha


Impax Labs: Promising Pipeline and a Possible Takeover Target
5/13/2010 1:39:00 PM - Seeking Alpha


China's Outsourcing Future: Rising Costs Are Not Necessarily a Bad Thing
5/13/2010 11:12:00 AM - Seeking Alpha


India Markets Thursday Wrap-Up: Trailing Asian Gainers
5/13/2010 7:57:00 AM - Seeking Alpha


Did Transgene Jump the Gun With Novartis?
5/11/2010 2:33:00 AM - Seeking Alpha


European Blue Chips Now Offer Excellent Investment Opportunities
5/9/2010 6:42:00 AM - Seeking Alpha


Vanda Pharmaceuticals Downgrade: Why I Don't Buy It
5/6/2010 4:58:00 AM - Seeking Alpha


Our Ugly Model Portfolio Strategies Continue to Generate Great Looking Alpha
5/3/2010 5:13:00 AM - Seeking Alpha


Three Trends That Will Impact Pharma's Future
4/30/2010 4:46:00 AM - Seeking Alpha


How Array Got Its Groove Back
4/28/2010 1:09:00 PM - Seeking Alpha


High Conviction: A Therapeutics Firm With a First-In-Class Treatment
4/27/2010 3:56:00 AM - Seeking Alpha


38 Foreign Dividend Stocks Traded in the U.S.
4/25/2010 8:53:00 AM - Seeking Alpha


Preview of AspenBio's Potentially Blockbuster Clinical Trials
4/25/2010 8:45:00 AM - Seeking Alpha


Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps?
4/22/2010 4:40:00 AM - Seeking Alpha


Fanapt First Quarter Sales Bode Well for Vanda, Novartis
4/21/2010 1:33:00 PM - Seeking Alpha


CytRx: All That Glitters Could be Gold
4/20/2010 6:01:00 PM - Seeking Alpha


Novartis Races to Be First With Oral MS Drug
4/19/2010 6:45:00 AM - Seeking Alpha


Abbott Must Hand Over CEO Emails: Biotech's Latest Trials and Tribulations
4/18/2010 11:18:00 AM - Seeking Alpha


Novartis, Roche Playing Hardball With U.K.
4/13/2010 2:39:00 PM - Seeking Alpha


FDA's Early Verdict on Cell Therapeutics' Pixuvri Comes as No Surprise
4/13/2010 4:23:00 AM - Seeking Alpha